First DCB Approved; DAPT Bleeds With Low LDL-C; Pre-CABG Cardiac Rehab Recent developments of interest in cardiovascular medicine Mar 05, 2024
FDA Says Eating Yogurt May Reduce Diabetes Risk Products will be allowed to carry claims as long as they don't mislead consumers Mar 04, 2024
SNAP Benefits and BP Meds; Post-PCI Anticoagulation Flop; CPAP's Potential Harm Recent developments of interest in cardiovascular medicine Feb 27, 2024
Bariatric Surgery a Long-Term Winner for Type 2 Diabetes Clinical trials show advantages over lifestyle, medication out to 12 years Feb 27, 2024
FDA: Don't Use Smartwatches, Smart Rings for Blood Glucose Measurements Noninvasive devices that don't pierce the skin can give inaccurate measurements Feb 22, 2024
TAVR Pioneer Dies; Allograft Rejection Criteria Need Work; Overeating Protein & CVD Recent developments of interest in cardiovascular medicine Feb 20, 2024
Denosumab Protective Against Diabetes? Study found lower diabetes incidence with osteoporosis drug for patients who stayed on treatment Feb 13, 2024
Salt Subs in Normal BP; Stroke Thrombectomy Without $$; Walmart's CVD Blood Test Recent developments of interest in cardiovascular medicine Feb 13, 2024
Rapid Weight Loss a Diabetic Retinopathy Risk? While research is conflicting, GLP-1 therapies might cause transient worsening of retinal disease Feb 12, 2024
Can a Common Diabetes Drug Turn Patients' Urine Into Alcohol? Case study highlights importance of proper urine sample storage Feb 07, 2024
Bariatric Surgery & BP Control; PFA Vasospasm Aftermath; Texas Cardiologist Arrested Recent developments of interest in cardiovascular medicine Feb 06, 2024
Durable Weight Loss Follows Just a Few Injections of Novel Drug Most of the body weight reduction persisted 150 days after the last dose in an early-phase trial Feb 05, 2024
Health Effects of Diabetes Remission; High-Deductible Plans for Cancer Patients Also in TTHealthWatch: USPSTF weighs in on screening for language disorders or delays in kids Feb 03, 2024 podcast
Cardiology Ups Diversity; Universal CVD Risk Predictor; 93-Year-Old Cardiologist Recent developments of interest in cardiovascular medicine Jan 30, 2024
Some 'Choosing Wisely' Recs Protect Older Folks From Low-Value Care Study looked at how three recommendations changed primary care decisions Jan 29, 2024
One Class of Antidiabetic Linked With Lower Kidney Stone Risk Study compared SGLT2 inhibitors with GLP-1 agonists and DPP-4 inhibitors Jan 29, 2024
Can the Eye Reveal Cardiac and Lung Disease -- Plus Much More? Researchers link thinner retinal layers to higher risk of multiple diseases Jan 26, 2024
Breast Cancer Drug Repurposed for Infant With Congenital Hyperinsulinism Daily treatment substantially reduced hypoglycemia over 13 weeks Jan 24, 2024
AI Tool Predicts PCI Outcomes; Shellfish Blood Clotter; Persuasive CAC Scan Images Recent developments of interest in cardiovascular medicine Jan 23, 2024
FDA Clears Wegovy, Other GLP-1 Drugs of Suicidality Risk for Now Preliminary evaluation reassures, while the agency's review continues Jan 11, 2024
BP Tracking Undergarment; COPD Exacerbations & HF Events; Hemolysis After PFA Recent developments of interest in cardiovascular medicine Jan 09, 2024
Maternal Type 1 Diabetes an Outsized Red Flag for Child Heart Defect Risk But don't ignore maternal overweight, obesity, and gestational diabetes, study says Jan 05, 2024
Study Assuages Fears of Pancreatic Cancer Risk With GLP-1 Receptor Agonists Researchers looked at 7-year patient data Jan 04, 2024
In Acute Kidney Disease, SGLT2 inhibitors Were All-Around Protective Risk of all-cause mortality, MAKE, and MACE were significantly reduced Jan 04, 2024
HCM Drug Hopeful; Pre-Cardiac Cath Fasting in Doubt; Way to Visualize LAAO Issues? Recent developments of interest in cardiovascular medicine Jan 02, 2024
Bernie Sanders Has COVID; Global Fake Ozempic Problem; Nitazenes, the New Fentanyl? Health news and commentary from around the Web gathered by ΒιΆΉ΄«Γ½ staff Dec 29, 2023
Nuclear Tracer Shortage; Weighing Post-Ablation OAC; Fix for Biased AI Tools? Recent developments of interest in cardiovascular medicine Dec 26, 2023
Food as Diabetes Medicine? Maybe Not, Trial Suggests But intensive program did help boost engagement with healthcare Dec 26, 2023
Deep Flaws in FDA's Device Oversight, and Patient Harm, Exposed in Lawsuits, Records "What is the threshold for the FDA to step in and do something?" Dec 24, 2023
HeartMate 3 Safety Concerns; First Cath Lab Standards for Kids; Single-Shot PFA Recent developments of interest in cardiovascular medicine Dec 19, 2023
Cannabis Exposure During Pregnancy; Tirzepatide Cessation and Weight Gain Also in TTHealthWatch: newer vaccine technologies in adults Dec 16, 2023 podcast
Stopping Tirzepatide Led to Weight Gain, Trial Shows But sustained treatment kept the pounds off Dec 13, 2023
Statins and CKD; Farxiga's Limited Symptom Improvement; Stop Wasted TNKase Recent developments of interest in cardiovascular medicine Dec 12, 2023
Metformin for Diabetes in Pregnancy: Maybe Not, Trial Says New trial complicates findings of previous studies Dec 12, 2023
GLP-1 Drugs Linked to Lower Colorectal Cancer Risk for Diabetes Patients Association strongest in patients with overweight, obesity Dec 07, 2023
Quick Albuminuria Reduction Key Factor in Finerenone's Efficacy 4-month UACR reduction mediated 84% of kidney treatment effect Dec 05, 2023
Win for Vegan Diet; Injectable Balloon Catheters OK'd; OAC Options After Failed DOAC Recent developments of interest in cardiovascular medicine Dec 05, 2023
Cost Hurdles Can Keep Patients From Accessing GLP-1 Receptor Agonists Pharmacists can intervene to educate, assist with cost, two studies suggest Dec 05, 2023
Pharmacists Can Spur Switch to Recommended Drugs for Diabetes Patients With CVD Intervention persuaded VA physicians to adjust care, helped lower HbA1c Dec 04, 2023
